11890 Federal Register / Vol. 75, No. 48 / Friday, March 12, 2010 / Notices 

all applicants. In addition, eliminating 

the error correction window will help 

NIH reduce the time needed to process 

applications and forward them through 

the peer review process. 

The error correction window was 

established at a time when an 

application could take multiple days to 

get processed by Grants.gov and NIH’s 

eRA systems. The lengthy processing 

time meant that applicants who applied 

on time might not receive feedback on 

the status of their submissions in time 

to address system identified errors/ 

warnings until after the due date, unless 

they applied well in advance. 

During the initial transition the error 

correction window also provided an 

opportunity for applicants to become 

familiar with the use of the new SF424 

(R&R) applications and the new way 

that long standing business rules would 

be enforced by electronic systems upon 

submission. 

Since 2005, combined system 

processing times have improved 

dramatically, with applications now 

taking minutes to process through both 

systems on average instead of days. This 

improvement provides applicants 

timely feedback on the status of their 

applications and allows them to address 

any system identified errors and 

warnings immediately, as the systems 

can process multiple submissions 

within a short period of time. NIH also 

has policies in place that do not rely on 

the error correction window to ensure 

that applicants are protected from 

possible eRA Commons or Grants.gov 

system issues that might keep an 

application from being received by the 

submission deadline. 

Additionally, elimination of the error 

correction window will not affect an 

applicant’s ability to submit late 

applications under the existing NIH 

Policy on Late Submission of Grant 

Applications (NOT–OD–06–086 

available at http://grants.nih.gov/grants/ 

guide/notice-files/NOT–OD–06– 

086.html) or for those who have 

provided substantial review service to 

NIH to take advantage of NIH’s 

continuous submission policy (http://

grants.nih.gov/grants/guide/notice-files/

NOT–OD–08–026.html). 

NIH is accepting comments from 

individuals and organizations on the 

impact of this change. We are also 

interested in feedback on possible 

timing of the change. Is there support 

for making the change in the next 3–6 

months, a year, or is more time needed 

to make the change should the agencies 

decide to move forward? 

Date: March 9, 2010. 

Sally J. Rockey, 

Acting Deputy Director for Extramural 

Research, National Institutes of Health. 

[FR Doc. 2010–5474 Filed 3–11–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10146] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Notice of Denial 

of Medicare Prescription Drug Coverage: 

Use: Section 1860D–4(g)(1) of the Social 

Security Act requires Part D plan 

sponsors that deny prescription drug 

coverage to provide a written notice of 

the denial to the enrollee. The purpose 

of this notice is to provide information 

to enrollees when prescription drug 

coverage has been denied, in whole or 

in part, by their Part D plans. The notice 

must be readable, understandable, and 

state the specific reasons for the denial. 

The notice must also remind enrollees 

about their rights and protections 

related to requests for prescription drug 

coverage and include an explanation of 

both the standard and expedited 

redetermination processes and the rest 

of the appeal process. For a list of 

changes, refer to the summary of 

changes document. Form Number: 

CMS–10146 (OMB#: 0938–0976); 

Frequency: Daily; Affected Public: 

Business or other for-profits; Number of 

Respondents: 456; Total Annual 

Responses: 290,344; Total Annual 

Hours: 145,172. (For policy questions 

regarding this collection contact 

Kathryn M. Smith at 410–786–7623. For 

all other issues call 410–786–1326.) 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web Site 

at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

In commenting on the proposed 

information collections please reference 

the document identifier or OMB control 

number. To be assured consideration, 

comments and recommendations must 

be submitted in one of the following 

ways by May 11, 2010: 

1. Electronically. You may submit 

your comments electronically to 

http://www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) accepting comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number, Room C4–26–05, 7500 

Security Boulevard, Baltimore, 

Maryland 21244–1850. 

Dated: March 8, 2010. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2010–5429 Filed 3–11–10; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–2744, CMS– 

10304 and CMS–10282] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 


srobinson on DSKHWCL6B1PROD with NOTICES